Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction.

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2024-08-01 Epub Date: 2024-05-24 DOI:10.1080/13625187.2024.2354248

Giampiero Capobianco, Elisa Sanna, Alessandra Gulotta, Giuseppe Virdis, Francesco Dessole, Ivana Maida, Massimo Madonia, Francesco Cudoni, Marco Petrillo

{"title":"Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfaction.","authors":"Giampiero Capobianco, Elisa Sanna, Alessandra Gulotta, Giuseppe Virdis, Francesco Dessole, Ivana Maida, Massimo Madonia, Francesco Cudoni, Marco Petrillo","doi":"10.1080/13625187.2024.2354248","DOIUrl":null,"url":null,"abstract":"Purpose of the article: The main aim of the study was to analyze the population of women who used etonogestrel implant, the reason that led them to this type of contraception, and the degree of compliance with it. Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n°47) over a 6-year period (2015-2021). We submitted the women a series of questions by telephone questionnaire (range 10-72 months after placements, mean 40 months) that investigated the comorbidities and side effects related to etonogestrel implant.Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n°47) over a 6-year period (2015-2021). We submitted the women a series of questions by telephone questionnaire (range 10-72 months after placements, mean 40 months) that investigated the comorbidities and side effects related to etonogestrel implant.Results: The average age of placement of etonogestrel implant was 33.8 ± 3.45 years. As regards level of education, 16/47 (34%) of the women had a university degree, 21/47 (44%) had a high school diploma and 10/47 (21%) had a secondary school diploma. The 12/47 (25%) of the women were, at the time of the counselling, unemployed and only 8% did not use in the past contraceptive methods other than etonogestrel implant. The 92% of women choose etonogestrel implant because it offered safe, comfortable and long-lasting contraception. Among the main side effects evaluated, we reported spotting in 24 out of 47 (51%), headache in 4 out of 47 (8.5%). The 85% of the women recommended etonogestrel implant to their friends as a contraceptive method, with an approval rating for the implant, expressed a rating from 1 to 10 with the mean that was 7.79, the median 8.Conclusions: Our results are of interest because they derive from a region of Italy in which the Long acting reversible contraception (LARC) is strongly underused. Etonogestrel implant was a safe and effective, long-acting, reversible hormonal contraception (LARC) and majority of women recommended the etonogestrel implant to their friends as a contraceptive method.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13625187.2024.2354248","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/24 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of the article: The main aim of the study was to analyze the population of women who used etonogestrel implant, the reason that led them to this type of contraception, and the degree of compliance with it. Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n°47) over a 6-year period (2015-2021). We submitted the women a series of questions by telephone questionnaire (range 10-72 months after placements, mean 40 months) that investigated the comorbidities and side effects related to etonogestrel implant.

Materials and methods: We carried out a retrospective study on women who had etonogestrel subcutaneous implant placed (n°47) over a 6-year period (2015-2021). We submitted the women a series of questions by telephone questionnaire (range 10-72 months after placements, mean 40 months) that investigated the comorbidities and side effects related to etonogestrel implant.

Results: The average age of placement of etonogestrel implant was 33.8 ± 3.45 years. As regards level of education, 16/47 (34%) of the women had a university degree, 21/47 (44%) had a high school diploma and 10/47 (21%) had a secondary school diploma. The 12/47 (25%) of the women were, at the time of the counselling, unemployed and only 8% did not use in the past contraceptive methods other than etonogestrel implant. The 92% of women choose etonogestrel implant because it offered safe, comfortable and long-lasting contraception. Among the main side effects evaluated, we reported spotting in 24 out of 47 (51%), headache in 4 out of 47 (8.5%). The 85% of the women recommended etonogestrel implant to their friends as a contraceptive method, with an approval rating for the implant, expressed a rating from 1 to 10 with the mean that was 7.79, the median 8.

Conclusions: Our results are of interest because they derive from a region of Italy in which the Long acting reversible contraception (LARC) is strongly underused. Etonogestrel implant was a safe and effective, long-acting, reversible hormonal contraception (LARC) and majority of women recommended the etonogestrel implant to their friends as a contraceptive method.

查看原文本刊更多论文

意大利撒丁岛使用依托诺孕酮皮下植入物的情况：妇女的依从性和满意度。

文章目的研究的主要目的是分析使用依托孕烯皮下埋植剂的妇女人群、导致她们使用这种避孕方式的原因以及对这种避孕方式的依从性。材料和方法我们对 6 年内（2015-2021 年）植入依托诺孕酮皮下埋植剂的女性（47 人）进行了回顾性研究。我们通过电话问卷向这些妇女（植入后 10-72 个月不等，平均 40 个月）提出了一系列问题，以调查与依托孕烯植入相关的合并症和副作用：我们对 6 年内（2015-2021 年）植入依托诺孕酮皮下植入物的女性（47 名）进行了回顾性研究。我们通过电话问卷向这些妇女（植入后 10-72 个月不等，平均 40 个月）提出了一系列问题，以调查与依托孕烯植入相关的合并症和副作用：结果：植入依托孕烯的平均年龄为（33.8 ± 3.45）岁。在教育程度方面，16/47（34%）的妇女拥有大学学位，21/47（44%）拥有高中文凭，10/47（21%）拥有中学文凭。在接受咨询时，12/47（25%）的妇女没有工作，只有 8%的妇女过去没有使用过除伊托诺孕酮皮下埋植剂以外的其他避孕方法。92%的妇女选择伊托诺孕酮皮下埋植剂，因为它能提供安全、舒适和持久的避孕效果。在评估的主要副作用中，我们发现 47 人中有 24 人（51%）出现点滴出血，47 人中有 4 人（8.5%）出现头痛。85%的妇女向她们的朋友推荐了依托孕烯植入剂作为避孕方法，她们对植入剂的认可度从 1 到 10 分不等，平均值为 7.79，中位数为 8.结论：我们的研究结果很有意义，因为这些结果来自意大利的一个地区，在该地区，长效可逆避孕药具（LARC）的使用率非常低。依托孕烯植入剂是一种安全有效的长效可逆荷尔蒙避孕药（LARC），大多数妇女都向她们的朋友推荐依托孕烯植入剂作为避孕方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.